ALVO Stock Analysis: Buy, Sell, or Hold?
ALVO - Alvotech Ordinary Shares
$3.61
0.03 (0.84%)
▲
5d:
+3.74%
30d:
+20.33%
90d:
-0.28%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When ALVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ALVO shows positive signals but monitor for confirmation. Market pricing in 2.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ALVO shows positive signals but monitor for confirmation. Market pricing in 2.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.49
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$4.65
22.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALVO is currently trading at $3.61, which is considered fair relative to its 30-day fair value range of $3.27 to $4.00. The stock's valuation (Forward PE: 14.9) is in line with its historical norms (15.9). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ALVO is in a downtrend. Immediate support is located at $3.45, while resistance sits at $4.01.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.60 (+304.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALVO is in a downtrend. Immediate support is located at $3.45, while resistance sits at $4.01.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.60 (+304.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.27 -
$4.00
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 304.4% below Wall St target ($14.60)
Trading Range Analysis
30-Day Trading Range
$3.27 -
$4.00
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.45
Resistance Level
$4.01
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.92
Wall Street Target
$14.60
(+304.4%)
Revenue Growth (YoY)
-20.2%
Earnings Growth (YoY)
-99.0%
Profit Margin
-14.4%
Valuation Discount vs History
-2.1% cheaper
PE vs Historical
14.9 vs 15.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.1%
(market-implied from PE analysis)
1-Year Target
$3.53
(-2%)
2-Year Target
$3.46
(-4%)
3-Year Target
$3.39
(-6%)
3-Yr Target (if PE normalizes)
(PE: 15→16)
$3.61
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 328.1%)
$17.78
(+393%)
Base:
(SPY PE: 14.9, Growth: 328.1%)
$12.18
(+238%)
Bear:
(PE: 12.7, Growth: 328.1%)
$10.36
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.9 to 15.9
Stabilization Target:
$3.85
(+6.5%)
PE Expansion Potential:
+6.5%
Share & Embed Analysis
Last updated: July 03, 2026 9:23 PM ET
Data refreshes hourly during market hours. Next update: 10:23 PM
Data refreshes hourly during market hours. Next update: 10:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 63 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
